CSIMarket
 


United Cannabis Corp  (CNAB)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

CNAB's Revenue Growth by Quarter and Year

United Cannabis's Revenue results by quarter and year




CNAB Revenue (in millions $) FY 2019 FY 2018 FY 2017 FY 2016
IV Quarter December - 2.98 -0.09 0.26
III Quarter September 4.72 2.13 0.10 0.20
II Quarter June 3.96 1.86 0.16 0.25
I Quarter March 4.41 0.27 0.19 -
FY   13.09 7.24 0.36 0.71



CNAB Revenue third quarter 2019 Y/Y Growth Comment
United Cannabis Corp reported Revenue surge of 121.79% year on year in the third quarter, to $ 4.72 millions, this is lower than United Cannabis Corp's recent average Revenue surge of 351.9%.

Looking into third quarter results within Biotechnology & Drugs industry 16 other companies have achieved higher Revenue growth. While United Cannabis Corp' s Revenue doubling of 121.79% ranks overall at the positon no. 218 in the third quarter.




CNAB Revenue ( Y/Y Growth %) 2019
2018 2017 2016
IV Quarter December - - - 100 %
III Quarter September 121.79 % 2030 % -50 % -35.48 %
II Quarter June 112.9 % 1062.5 % -36 % 177.78 %
I Quarter March 1533.33 % 42.11 % - -
FY   - 1911.11 % -49.3 % 12.7 %

Financial Statements
United Cannabis's third quarter 2019 Revenue $ 4.72 millions CNAB's Income Statement
United Cannabis's third quarter 2018 Revenue $ 2.13 millions Quarterly CNAB's Income Statement
New: More CNAB's historic Revenue Growth >>


CNAB Revenue (Quarter on Quarter Growth %)

2019
2018 2017 2016
IV Quarter December - 39.91 % - 30 %
III Quarter September 19.3 % 14.52 % -37.5 % -20 %
II Quarter June -10.2 % 588.89 % -15.79 % -
I Quarter March 47.99 % - -26.92 % -
FY (Year on Year)   - 1911.11 % -49.3 % 12.7 %




Revenue third quarter 2019 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #17
Healthcare Sector #62
Overall #218

Revenue Y/Y Growth Statistics
High Average Low
1977.05 % 351.9 % -100 %
(Sep 30 2018)   (Dec 31 2015)
Revenue third quarter 2019 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #17
Healthcare Sector #62
Overall #218
Revenue Y/Y Growth Statistics
High Average Low
1977.05 % 351.9 % -100 %
(Sep 30 2018)   (Dec 31 2015)

Revenue by Quarter for the Fiscal Years 2016, 2017, 2018, 2019

United Cannabis's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
599.21 % 51.17 % -100 %
(Jun 30 2018)  


CNAB's III. Quarter Q/Q Revenue Comment
United Cannabis Corp achieved in the III. Quarter 2019 below company average Revenue jump of 19.3% quarter on quarter, to $ 4.72 millions.

Although the III. Quarter 2019 CNAB's Revenue Q/Q growth was beneath the regular of 51.17 %, it was yet promising story, as the current expension, eclipses the 14.52% surge in the same quarter a year ago

Within Biotechnology & Drugs industry 33 other companies have achieved higher Revenue quarter on quarter growth. While United Cannabis's Revenue growth quarter on quarter, overall rank is 473.


Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #34
Healthcare Sector #113
Overall #473
Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #34
Healthcare Sector #113
Overall #473
Revenue Q/Q Growth Statistics
High Average Low
599.21 % 51.17 % -100 %
(Jun 30 2018)  


CNAB's III. Quarter Q/Q Revenue Comment
United Cannabis Corp achieved in the III. Quarter 2019 below company average Revenue jump of 19.3% quarter on quarter, to $ 4.72 millions.

Although the III. Quarter 2019 Revenue sequential growth was below the average of 51.17 %, this has been still promising story, as the III. Quarter expension, outshines the 14.52% Revenue rise in the III. Quarter a year ago

Within Biotechnology & Drugs industry 33 other companies have achieved higher Revenue quarter on quarter growth. While United Cannabis's Revenue growth quarter on quarter, overall rank is 473.


United Cannabis's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2019)
12 Months Ending
(Jun 30 2019)
12 Months Ending
(Mar 31 2019)
12 Months Ending
(Dec 31 2018)
12 Months Ending
(Sep 30 2018)
Cumulative Revenue 12 Months Ending $ 16.08 $ 13.49 $ 11.39 $ 7.24 $ 4.17
Y / Y Revenue Growth (TTM) 286.01 % 531.39 % 2495.16 % 1899.49 % 477.5 %
Year on Year Revenue Growth Overall Ranking # 69 # 29 # 15 # 149 # 54
Seqeuential Revenue Change (TTM) 19.21 % 18.43 % 57.23 % 73.89 % 94.99 %
Seq. Revenue Growth (TTM) Overall Ranking # 251 # 236 # 62 # 11 # 16




Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Sep 30 2019 period, United Cannabis's cumulative twelve months Revenue were $ 16 millions, company would post below average annual Revenue growth of 94.99% year on year, if the fiscal year would end at Sep 30 2019.
A slow-down in the United Cannabis's Revenue growth from the 3.96% growth in Jun 30 2019.

Among companies within the Healthcare sector 17 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 29 to 69.

Revenue TTM Q/Q Growth Statistics
High Average Low
386.79 %
95.95 %
18.43 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry # 17
Healthcare Sector # 18
Overall # 69

Revenue TTM Y/Y Growth Statistics
High Average Low
2495.16 %
828.61 %
-51.09 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 17
Sector # 62
S&P 500 # 251
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Sep 30 2019 period, United Cannabis's cumulative twelve months Revenue were $ 16 millions, company would post below average annual Revenue growth of -51.09% year on year, if the fiscal year would end at Sep 30 2019.
A slow-down in the United Cannabis's Revenue growth from the 3.96% growth in Jun 30 2019.

Among companies within the Healthcare sector 17 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 29 to 69.

Revenue TTM Q/Q Growth Statistics
High Average Low
386.79 %
95.95 %
18.43 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry # 17
Healthcare Sector # 18
Overall # 69

Revenue TTM Y/Y Growth Statistics
High Average Low
2495.16 %
828.61 %
-51.09 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 17
Sector # 62
S&P 500 # 251




Other Revenue Growth
Biotechnology & Drugs Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
CNAB's Revenue Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for CNAB's Competitors
Revenue Growth for United Cannabis's Suppliers
Revenue Growth for CNAB's Customers

You may also want to know
CNAB's Annual Growth Rates CNAB's Profitability Ratios CNAB's Asset Turnover Ratio CNAB's Dividend Growth
CNAB's Roe CNAB's Valuation Ratios CNAB's Financial Strength Ratios CNAB's Dividend Payout Ratio
CNAB's Roa CNAB's Inventory Turnover Ratio CNAB's Growth Rates CNAB's Dividend Comparisons



Companies with similar Revenue jump for the quarter ending Sep 30 2019 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2019
Flexion Therapeutics Inc   211.67 %$ 211.674 millions
Yield10 Bioscience Inc   194.74 %$ 194.737 millions
Tetraphase Pharmaceuticals Inc  190.18 %$ 190.182 millions
Palatin Technologies Inc  182.22 %$ 182.217 millions
Guardant Health Inc   180.51 %$ 180.509 millions
Regenxbio Inc   177.04 %$ 177.045 millions
Zyla Life Sciences  174.57 %$ 174.574 millions
Portola Pharmaceuticals inc   159.57 %$ 159.568 millions
Aerie Pharmaceuticals Inc   153.96 %$ 153.958 millions
Endonovo Therapeutics Inc   153.63 %$ 153.633 millions
Vbi Vaccines Inc  149.81 %$ 149.807 millions
Ibio Inc   140.00 %$ 140.000 millions
Corbus Pharmaceuticals Holdings Inc   137.40 %$ 137.404 millions
Amicus Therapeutics inc   136.78 %$ 136.784 millions
Fate Therapeutics Inc  136.74 %$ 136.745 millions
Chemocentryx Inc   135.79 %$ 135.788 millions
Amyris Inc   135.12 %$ 135.120 millions
American Cannabis Company Inc   131.04 %$ 131.042 millions
United Cannabis Corp  121.55 %$ 121.551 millions
Ultragenyx Pharmaceutical Inc   119.33 %$ 119.332 millions
Healthlynked Corp  117.29 %$ 117.292 millions
Heron Therapeutics Inc   115.43 %$ 115.425 millions
Biodelivery Sciences International Inc   114.09 %$ 114.086 millions
Spark Therapeutics Inc   109.65 %$ 109.648 millions
Apyx Medical Corp  106.29 %$ 106.291 millions
Newlink Genetics Corp  105.00 %$ 105.000 millions
Tandem Diabetes Care Inc   104.60 %$ 104.602 millions
Amarin Corp Plcuk  103.18 %$ 103.185 millions
Novan Inc   103.09 %$ 103.086 millions
Catasys Inc   102.45 %$ 102.449 millions


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

ESIO's Profile

Stock Price

ESIO's Financials

Business Description

Fundamentals

Charts & Quotes

ESIO's News

Suppliers

ESIO's Competitors

Customers & Markets

Economic Indicators

ESIO's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071